IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

Market Cap	21.75B +2.5%
Revenue (ttm)	22.27B +8.4%
Net Income	1.16B +19.2%
EPS	3.95 +19.2%
Shares Out	n/a
PE Ratio	18.77
Forward PE	14.77
Dividend	1.00 (1.38%)
Ex-Dividend Date	Feb 17, 2026

Volume	165,936
Average Volume	828,949
Open	74.00
Previous Close	74.10
Day's Range	72.87 - 74.37
52-Week Range	57.50 - 126.66
Beta	0.04
RSI	45.08
Earnings Date	Feb 11, 2026

About NSE:IOLCP

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. The Pharmaceutical segment provides active pharmaceutical ingredients, such as ibuprofen, metfo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1986
• Employees: 2,891
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: IOLCP

Financial Performance

In fiscal year 2025, NSE:IOLCP's revenue was 20.79 billion, a decrease of -2.51% compared to the previous year's 21.33 billion. Earnings were 1.01 billion, a decrease of -24.82%.